Page last updated: 2024-08-25

secnidazole and HIV Coinfection

secnidazole has been researched along with HIV Coinfection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chavoustie, S; Kaufman, G; Muzny, CA; Van Gerwen, OT1
Hernán, A; Jiménez, JC; Núñez, L; Pérez-Chacón, G; Pocaterra, LA; Rojas, E1

Trials

1 trial(s) available for secnidazole and HIV Coinfection

ArticleYear
Efficacy of single-dose oral secnidazole for the treatment of trichomoniasis in women co-infected with trichomoniasis and bacterial vaginosis: a post hoc subgroup analysis of phase 3 clinical trial data.
    BMJ open, 2023, 08-07, Volume: 13, Issue:8

    Topics: Coinfection; Female; HIV Infections; Humans; Male; Trichomonas Infections; Vaginosis, Bacterial

2023

Other Studies

1 other study(ies) available for secnidazole and HIV Coinfection

ArticleYear
Coinfection with
    The American journal of tropical medicine and hygiene, 2017, Volume: 96, Issue:5

    Topics: Adult; Animals; Anthelmintics; Anti-HIV Agents; Antiprotozoal Agents; Coinfection; Diarrhea; Giardia lamblia; Giardiasis; HIV; HIV Infections; Humans; Hymenolepiasis; Hymenolepis diminuta; Hymenolepis nana; Male; Metronidazole; Nitro Compounds; Praziquantel; Thiazoles; Treatment Outcome; Weight Loss

2017